Approval · Notice of Compliance 23006 · 2019
ACT DEXTROAMPHETAMINE SR: Notice of Compliance 23006
Issued December 11, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23006
- Date
- December 11, 2019
- Company
- Teva Canada LimitedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Merger - buyout
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACT DEXTROAMPHETAMINE SR | 02448319 | Marketed |
| ACT DEXTROAMPHETAMINE SR | 02448327 | Marketed |
Medicinal ingredients
- DEXTROAMPHETAMINE SULFATE 10 MG per CAP
- DEXTROAMPHETAMINE SULFATE 15 MG per CAP